Detalhe da pesquisa
1.
Homologous recombination deficiency (HRD) status predicts response to standard neoadjuvant chemotherapy in patients with triple-negative or BRCA1/2 mutation-associated breast cancer.
Breast Cancer Res Treat
; 168(3): 625-630, 2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-29275435
2.
Autoimmune Disease in Patients With Advanced Thymic Epithelial Tumors.
JTO Clin Res Rep
; 3(5): 100323, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35601925
3.
Impact of Tumor Suppressor Gene Co-Mutations on Differential Response to EGFR TKI Therapy in EGFR L858R and Exon 19 Deletion Lung Cancer.
Clin Lung Cancer
; 23(3): 264-272, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34838441
4.
Predictive Model to Guide Brain Magnetic Resonance Imaging Surveillance in Patients With Metastatic Lung Cancer: Impact on Real-World Outcomes.
JCO Precis Oncol
; 6: e2200220, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-36201713
5.
Clinical Implications of KEAP1-NFE2L2 Mutations in NSCLC.
J Thorac Oncol
; 16(3): 395-403, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33307193
6.
Role of Consolidation Durvalumab in Patients With EGFR- and HER2-Mutant Unresectable Stage III NSCLC.
J Thorac Oncol
; 16(5): 868-872, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33539970
7.
Genomic clustering analysis identifies molecular subtypes of thymic epithelial tumors independent of World Health Organization histologic type.
Oncotarget
; 12(12): 1178-1186, 2021 Jun 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34136086
8.
Durvalumab for Stage III EGFR-Mutated NSCLC After Definitive Chemoradiotherapy.
J Thorac Oncol
; 16(6): 1030-1041, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33588109
9.
Genetic Determinants of EGFR-Driven Lung Cancer Growth and Therapeutic Response In Vivo.
Cancer Discov
; 11(7): 1736-1753, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33707235
10.
Adjuvant Chemotherapy.
Thorac Surg Clin
; 30(2): 179-185, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-32327176
11.
Everolimus in the treatment of metastatic thymic epithelial tumors.
Lung Cancer
; 149: 97-102, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33007678
12.
Role of KEAP1/NFE2L2 Mutations in the Chemotherapeutic Response of Patients with Non-Small Cell Lung Cancer.
Clin Cancer Res
; 26(1): 274-281, 2020 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31548347
13.
Role of Immunotherapy in Small Cell Lung Cancer, Thymic Epithelial Tumors, and Mesothelioma.
Am Soc Clin Oncol Educ Book
; 39: 543-552, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31099677
14.
Impact of KEAP1/NFE2L2/CUL3 mutations on duration of response to EGFR tyrosine kinase inhibitors in EGFR mutated non-small cell lung cancer.
Lung Cancer
; 134: 42-45, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31319993
15.
Phase II trial of single agent amrubicin in patients with previously treated advanced thymic malignancies.
Lung Cancer
; 137: 71-75, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31557562
16.
Are maternal and community risk factors associated with the presence of asthma among children placed in foster care?
Child Youth Serv Rev
; 35(1): 128-132, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25673901
17.
Warfarin utilisation and anticoagulation control in patients with atrial fibrillation and chronic kidney disease.
Heart
; 103(11): 818-826, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27852694
18.
Impact of Baseline Stroke Risk and Bleeding Risk on Warfarin International Normalized Ratio Control in Atrial Fibrillation (from the TREAT-AF Study).
Am J Cardiol
; 119(2): 268-274, 2017 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27836133
19.
Consolidation Durvalumab Should Not Be Administered to Patients With Stage III EGFR-Mutant NSCLC.
J Thorac Oncol
; 16(12): 1994-1998, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34809803
20.
Erratum: Pregnancy Complicated by Gorham-Stout Disease and Refractory Chylothorax.
AJP Rep
; 6(4): e384, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27822433